Case Report

Primary Cutaneous Cryptococcosis in a Lung Transplant Recipient

Authors: Katherine L. Baumgarten, MD, Vincent G. Valentine, MD, FCCP, Julia B. Garcia-Diaz, MD, MS

Abstract

Cryptococcal skin lesions are found in 10 to 15% of patients with disseminated cryptococcosis. Primary skin inoculation by Cryptococcus neoformans is rare but has been reported. We report the first known case of primary cutaneous cryptococcosis in a lung transplant recipient. Our patient, a 57-year-old man, underwent left single-lung transplantation and presented with a nonhealing ulcer 50 months later. Skin histopathology and culture confirmed C neoformans. Serum and cerebrospinal fluid cryptococcal antigen tests were negative. The lesion healed after treatment with fluconazole. To date, disseminated disease is not evident. Primary cutaneous cryptococcosis has been reported in kidney and liver recipients but not in lung transplantation recipients. Nonhealing ulcers in immunocompromised patients mandate aggressive diagnostic procedures. Differential diagnosis of these cutaneous lesions should consider fungi, including C neoformans.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Antony SA, Antony SJ. Primary cutaneous Cryptococcus in nonimmu-nocompromised patients.Cutis 1995;56:96–98.
 
2. Cawley EP, Grekin RH, Cutis AC. Torulosis: A review of the cutaneous and adjoining mucous membrane manifestations. J Invest Dermatol 1950;14:327–344.
 
3. Diamond RD. Cryptococcus neoformans, in Mandell GL, Bennett JE, Dolin R (eds):Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. New York, Churchill Livingstone, 1995, ed 4, pp 2331–2340.
 
4. Singh N, Gayowski T, Wagener MM, et al. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 1997;11:66–70.
 
5. Mayers DL, Martone WJ, Mandell GL. Cutaneous cryptococcosis mimicking Gram-positive cellulitis in a renal transplant patient. South Med J 1981;74:1032–1033.
 
6. Anderson DJ, Schmidt C, Goodman J, et al. Cryptococcal disease presenting as cellulitis. Clin Infect Dis 1992;14:666–672.
 
7. Lui H, McLeod WA, Wood WS. An ulcerated plaque in a gay man: Cutaneous cryptococcosis. Arch Dermatol 1993;129:499, 501–502.
 
8. Pema K, Diaz J, Guerra LG, et al. Disseminated cutaneous cryptococ-cosis: Comparison of clinical manifestations in the pre-AIDS and AIDS eras. Arch Intern Med 1994;154:1032–1034.
 
9. Pappas P, Perfect J, Henderson H, et al. Cryptococcosis in non-HIV infected patients: A multicenter survey. Infectious Diseases Society of America, 35th annual meeting, San Francisco, CA, 1997 (Abstract 128).
 
10. Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis: A sentinel of disseminated disease. Arch Dermatol 1971;104:1–3.
 
11. Glaser JB, Garden A. Inoculation of cryptococcosis without transmission of the acquired immunodeficiency syndrome. N Engl J Med 1985; 313:266 (letter).
 
12. Iacobellis FW, Jacobs MI, Cohen RP. Primary cutaneous cryptococcosis. Arch Dermatol1979;115:984–985.
 
13. Noble RC, Fajardo LF. Primary cutaneous cryptococcosis: Review and morphologic study. Am J Clin Pathol 1972;57:13–22.
 
14. Vogelaers D, Petrovic M, Deroo M, et al. A case of primary cutaneous cryptococcosis. Eur J Clin Microbiol Infect Dis 1997;16:150–152.
 
15. Bohne T, Sander A, Pfister-Wartha A, et al. Primary cutaneous cryptococcosis following trauma of the right forearm. Mycoses 1996;39:457–459.
 
16. Goonetilleke AK, Krause K, Slater DN, et al. Primary cutaneous cryptococcosis in an immunocompromised pigeon keeper. Br J Dermatol 1995;133:650–652.
 
17. Naka W, Masuda M, Konohana A, et al. Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin Exp Dermatol 1995;20:221–225.
 
18. Ng WF, Loo KT. Cutaneous cryptococcosis: Primary versus secondary disease—Report of two cases with review of literature. Am J Dermatopathol 1993;15:372–377. [Erratum:Am J Dermatopathol1994 Apr; 16(2):227.]
 
19. Cusini M, Cagliani P, Grimalt R, et al. Primary cutaneous cryptococcosis in a patient with the acquired immunodeficiency syndrome. Arch Dermatol 1991;127:1848–1849 (letter).
 
20. Salm R, Groth D, Kappe R, et al. Primary cutaneous cryptococcosis after microtrauma of the right index finger. Mycoses 1988(Suppl 1):88–92.
 
21. Butler WP, Kaufer GI. Primary cutaneous cryptococcosis successfully treated with outpatient amphotericin B and 5-fluorocytosine. NITA 1985;8:295–297.
 
22. Baes H, Van Cutsem J. Primary cutaneous cryptococcosis. Dermatologica 1985;171:357–361.
 
23. Sussman EJ, McMahon F, Wright D, et al. Cutaneous cryptococcosis without evidence of systemic involvement. J Am Acad Dermatol 1984;11:371–374.
 
24. Bee OB, Tan T, Pang R. A case of primary cutaneous cryptococcosis successfully treated with miconazole. Arch Dermatol 1981;117:290–291.
 
25. Rao TV, Rao KS, Satyanarayana CV. Primary cutaneous cryptococcal granuloma in a child. J Pediatr Surg 1976;11:267–268.
 
26. Abdel-Fattah A, Zeid MS, Ghaly AF. Primary cutaneous cryptococcosis in Egypt. Int J Dermatol1975;14:606–609.
 
27. Handa S, Nagaraja, Chakraborty A, et al. Primary cutaneous cryptococcosis in an immune competent patient. J Eur Acad Dermatol Venereol 1998;10:167–169.
 
28. Micalizzi C, Persi A, Parodi A. Primary cutaneous cryptococcosis in an immunocompetent pigeon keeper. Clin Exp Dermatol 1997;22:195–197.
 
29. Bellosta M, Gaviglio MR, Mosconi M, et al. Primary cutaneous cryptococcosis in an HIV-negative patient. Eur J Dermatol 1999;9:224–226.
 
30. Hurwich BJ, Domonkos AN. Primary cutaneous cryptococcosis: Seroimmunologic and fluorescent antibody studies. N Y State J Med 1970;70:1075–1079.
 
31. Burlage AM, Fuller P, Mikolich DJ, et al. Cutaneous cryptococcus in a nonimmunocompromised host. Infect Dis Clin Pract 1997;6:410–412.
 
32. Sethi KK, Salfelder K, Schwarz J. Experimental cutaneous primary infection with Cryptococcus neoformans (Sanfelice) Vuillemin. Mycopathol Mycol Appl 1965;27:357–368.
 
33. High KP. The antimicrobial activities of cyclosporine, FK506, and rapamycin. Transplantation1994;57:1689–1700.
 
34. Saag MS, Graybill RJ, Larsen RA, et al; Infectious Diseases Society of America. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710–718.
 
35. Pfaller MA, Zhang J, Messer SA, et al. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 1999;43:169–171.
 
36. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol1998;36:198–202.
 
37. Abruzzo GK, Flattery AM, Gill CJ, et al. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.Antimicrob Agents Chemother 1997;41:2333–2338.
 
38. Espinel-Ingroff A. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998;36:2950–2956.
 
39. Feldmesser M, Kress Y, Mednick A, et al. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J Infect Dis 2000;182:1791–1795.